1st Edition
Pathology, Toxicogenetics, and Criminalistics of Drug Abuse
Extracted from the Drug Abuse Handbook, 2nd edition, to give you just the information you need at an affordable price.
Pathology, Toxicogenetics, and Criminalistics of Drug Abuse presents a detailed introduction to the cutting-edge advances in this emerging field. Beginning with a definition and explanation of the scheduling of controlled substances, the book covers all illicit drugs, as well as several legitimate pharmaceutical preparations that are used illicitly, including steroids. It describes in detail the most common pathologic syndromes seen in the hearts, lungs, and central nervous systems of drug abusers and explains how inherited genetic defects and variations can alter drug effects. Written by leading investigators in the field, this useful volume describes the techniques most commonly used by forensic analysts including chemical confirmatory tests such as microcrystal identification and gas chromatography/mass spectrometry. The book reviews the basics of toxicogenetics, including the molecular changes in cardiac structure ("channelopathies") that may cause sudden death.
Definition and Scheduling of Controlled Substances
Scheduling of Controlled Substances
Controlled Substance Analogue Enforcement Act of 1986
Controlled Substances
Legitimate Pharmaceutical Preparations
Unique Identify Factors
Analyzing Drugs in the Forensic Science Laboratory
Comparative Analysis
Clandestine Laboratories
Pathology of Drug Abuse, Edited by C. V. Wetli
The Scene of Death and the Autopsy
Heart Disease
Myocardial Alterations in Drug Abusers, S. B. Karch
Valvular Heart Disease, M. D. Bell
Lung Disease, M. D. Bell
Disorders of the Central Nervous System, M. Bell
Post-Mortem Toxicology, Edited by H. Druid
Introduction to Postmortem Toxicology, W. L. Hearn and H. C. Walls
Specimen Selection, Collection, Preservation, and Security, B. R. Hepler and D. S. Isenschmid
Common Methods in Post-Mortem Toxicology, W. L. Hearn and H. C. Walls
Strategies for Post-Mortem Toxicology Investigation, Edited and Revised by H. Druid, From the original by W. L. Hearn
Quality Assurance in Post-Mortem Toxicology, W. Andollo
Interpretation of Post-Mortem Drug Levels, G. R. Jones
Toxicogenetics
Pharmacogenomics for Toxicology, R. M. White, Sr. and S. H. Y. Wong
Heritable Channelopathies and Myopathies, K. A. Glatter, J. Calkins, and S. J. Ayirookuzhi
Biography
Steven B. Karch MD, FFFLM